Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4945 total record number 317 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 32 out of 34
336 citations found

Differential role of the interleukin-17 axis and neutrophils in resolution of inhalational anthrax

Garraud, K;Cleret, A;Mathieu, J;Fiole, D;Gauthier, Y;Quesnel-Hellmann, A;Tournier, JN;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

In situ gastrointestinal protection against anthrax edema toxin by single-chain antibody fragment producing lactobacilli

Andersen KK, Marcotte H, lvarez B, Boyaka PN, Hammarstrm L

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

  • Enzyme-Linked ImmunoSorbent Assay (ELISA):

    96 well microtiter plates (EIR/RIA plate, Costar, Lowell, MA) were coated with 100 l rPA (List labs, Campbell, CA) at 1 g/ml in PBS overnight (o/n) at 4C. Plates were subsequently blocked with 200 l 1% BSA (in PBS containing 0.05% Tween 20, PBS-T) for two hours at 4C. …

A non-glycosylated, plant-produced human monoclonal antibody against anthrax protective antigen protects mice and non-human primates from B. anthracis spore challenge

Mett V, Chichester JA, Stewart ML, Musiychuk K, Bi H, Reifsnyder CJ, Hull AK, Albrecht MT, Goldman S, Baillie LW, Yusibov V

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in Rabbits

Li Q, Peachman KK, Sower L, Leppla SH, Shivachandra SB, Matyas GR, Peterson JW, Alving CR, Rao M, Rao VB

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Kinetics of Lethal Factor and Poly-D-Glutamic Acid Antigenemia during Inhalation Anthrax in Rhesus Macaques

Boyer AE, Quinn CP, Hoffmaster AR, Kozel TR, Saile E, Marston CK, Percival A, Plikaytis BD, Woolfitt AR, Gallegos M, Sabourin P, McWilliams LG, Pirkle JL, Barr JR

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

  • LF quantification:

    … To achieve the necessary dynamic range and to account for high-sensitivity rapid-response sample analysis, two standard curves were prepared, one for 20 ng/ml, l (low volume [LV]) and the other for 200 ng/ml, l (high volume [HV]) serum volumes. In addition, three quality control samples (QCs) were prepared in human serum pools (Interstate Blood Bank, Memphis, TN) using recombinant LF (List Biological Laboratory, Campbell, CA) and validated. …

    PA antigen capture immunoassay:

    Microtiter plates (Thermo Labsystems, Franklin, MA) were coated with monoclonal anti-PA antibody AVR1046 obtained by the same methodologies used for anti-LF monoclonal described previously (4) at 1.28 g/ml in 0.01 M phosphate-buffered saline (PBS), pH 7.4. Coated plates were washed with a wash buffer consisting of PBS and 0.1% Tween 20, pH 7.4. Recombinant PA (rPA; List Biological Laboratories, Inc., Campbell, CA) was serially diluted twofold using a 1/25 or a 1/100 dilution of normal rhesus macaque serum (RMS). The rPA dilutions formed a seven-point standard curve from 0.6 to 37.5 ng/ml. …

    Author did not indicate which specific lethal factor was utilized.  List Labs provides Product #172 (Anthrax Lethal Factor (LF), Recombinant from B. anthracis) and Product #169 (Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence).

Efficient Neutralization of Antibody-Resistant Forms of Anthrax Toxin by a Soluble Receptor Decoy Inhibitor

Sharma S, Thomas D, Marlett J, Manchester M, Young JA

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Genetic Vaccines for Anthrax Based on Recombinant Adeno-associated Virus Vectors

Liu TH, Oscherwitz J, Schnepp B, Jacobs J, Yu F, Cease KB, Johnson PR

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Role of N-Terminal Amino Acids in the Potency of Anthrax Lethal Factor

Gupta PK, Moayeri M, Crown D, Fattah RJ, Leppla SH

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

  • Samples of LF used for comparison were purchased from List Biological Laboratories (Campbell, CA).

    Results – Toxicities of LF proteins produced from avirulent B. anthracis strains:

    … B. anthracis strains cured of the pXO1 and pXO2 virulence plasmids [18]. LF expressed from pSJ115 is here termed LF-HMA to denote the presence of the two residues His-Met (HM) added at its N-terminus due to the cloning manipulations. This expression system is licensed to List Biological Laboratories (Campbell, CA), and the LF sold by them is therefore also LF-HMA. …

Anthrax lethal toxin induces cell death-independent permeability in zebrafish vasculature

Bolcome, RE III; Sullivan, SE; Zeller, R; Barker, AP; Collier, RJ; Chan, J

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

A Viral Nanoparticle with Dual Function as an Anthrax Antitoxin and Vaccine

Manayani DJ, Thomas D, Dryden KA, Reddy V, Siladi ME, Marlett JM, Rainey GJ, Pique ME, Scobie HM, Yeager M, Young JA, Manchester M, Schneemann A

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

  • Quantification of PA83 bound to chimeras 206 and 264:

    Recombinant PA83 (List Biological Laboratories) in 5 mM Hepes, 50 mM NaCl (pH 7.5) was mixed with purified chimeras 206 and 264 in 50 mM Hepes (pH 7.5) in a ratio of 180:1 (equimolar amounts of PA83and VWA domains). Following incubation for 20 min at room temprature, an aliquot from each of the samples was removed and stored at 20 C pending analysis. The remainder of the samples was transferred to an ultracentrifuge tube and underlayed with a 30% (w/w) sucrose cushion in 50 mM Hepes (pH 7.5). Complexes of chimeras decorated with PA83 were pelleted by centrifugation at 200,000g for 45 min. …